FOXA1 and cancer: Their research demonstrated that the FOXA1 expression level in cancer tissues was significantly higher among CRC cases compared to noncancer specimens, and positive expression of FOXA1 in cancer tissues was associated with poor clinicopathological characteristics as well as poor prognosis of CRC.28